Safety and effectiveness of direct oral anticoagulants for venous thromboembolism in patients with active cancer: a retrospective study

被引：0
|
作者：
Ogatal, M. [1 ]
Satake, H. [2 ]
Ama, Y. [1 ]
Hirabatake, M. [1 ]
Ogata, T. [1 ]
Yasui, H. [3 ]
Hashida, T. [1 ]
机构：
[1] Kobe City Med Ctr, Gen Hosp, Kobe, Hyogo, Japan
[2] Kansai Med Univ Hosp, Canc Treatment Ctr, Hirakata, Osaka, Japan
[3] Kobe City Med Ctr, Dept Med Oncol, Gen Hosp, Kobe, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 165
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [31] Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min
    Cline, Lauren
    Generoso, Erika Marie G.
    D'Apice, Nicholas
    Dellinger, Sara K.
    Tovey, Amber
    Clark, Nathan P.
    Nui, Fang
    Hui, Rita
    Hale, Stephanie A.
    Ramsey, Tanya
    Pontoppidan, Kimi
    Ekmekdjian, Hasmig
    Fink, Kristen
    Witt, Daniel M.
    Crowther, Mark A.
    Delate, Thomas
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (02) : 355 - 364
  • [32] Direct oral anticoagulants and venous thromboembolism
    Franchini, Massimo
    Mannucci, Pier Mannuccio
    EUROPEAN RESPIRATORY REVIEW, 2016, 25 (141) : 295 - 302
  • [33] SAFETY OF DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF THROMBOEMBOLISM IN PEDIATRIC CANCER PATIENTS
    Scheuermann, Amanda
    Malec, Lynn
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S23 - S24
  • [34] Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis
    Ross, Jeremy A.
    Miller, Marilyn M.
    Hernandez, Cristhiam M. Rojas
    THROMBOSIS RESEARCH, 2017, 150 : 86 - 89
  • [35] Cost-effectiveness of direct oral anticoagulants for cancer-associated venous thromboembolism
    King, J.
    Bhat, S.
    Heath, L. J.
    Derington, C. G.
    Yu, Z.
    Clark, N. P.
    Witt, D. M.
    Reynolds, K.
    Lang, D. T.
    Xu, S.
    Bellows, B. K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3140 - 3140
  • [36] Comparative Effectiveness and Safety of Direct Oral Anticoagulants (DOAC) Versus Conventional Anticoagulation for the Treatment of Cancer-Related Venous Thromboembolism: A Retrospective Analysis
    Ross, Jeremy A.
    Miller, Marilyn
    Hernandez, Cristhiam M. Rojas
    BLOOD, 2015, 126 (23)
  • [37] Outcome of Elderly Patients with Venous Thromboembolism Treated with Direct Oral Anticoagulants-A Retrospective Cohort Study
    Ayalon-Dangur, Irit
    Vega, Yakov
    Israel, Miriam Rozi
    Grossman, Alon
    Spectre, Galia
    Shochat, Tzippy
    Leibovici, Leonard
    Gafter-Gvili, Anat
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [38] Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study
    El-Bardissy, Ahmed
    Elshafei, Mohamed Nabil
    Abdelgawad, Hebatullah
    Mekkawi, Rana
    Eltahir, Asma
    Mohammed, Abdulmoqeeth
    Ashour, A. M.
    Elewa, Hazem
    THROMBOSIS JOURNAL, 2025, 23 (01):
  • [39] Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism
    Zeng, Jie
    Zhang, Xuhui
    Lip, Gregory Y. H.
    Shu, Xiaochen
    Thabane, Lehana
    Tian, Junzhang
    Li, Guowei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [40] Recurrent venous thromboembolism in cancer patients treated with direct oral anticoagulants.
    Talbot, Alice
    Dean, Andrew Peter
    Brennan, Ciara
    Talbot, Thomas
    Angelov, Sophia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345